Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Callos

The proxy statement of Cytokinetics Inc reports total compensation of $3,787,644 for Andrew Callos in fiscal 2025, including a base salary of $581,678. Disclosed compensation is on record for 4 fiscal years. Andrew Callos has spoken on 1 earnings call across 1 company, most recently for Cytokinetics Inc on August 6, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cytokinetics Inc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cytokinetics Inc (CYTK) $581,678 $3,787,644
2024 Cytokinetics Inc (CYTK) $562,913 $4,389,027
2023 Cytokinetics Inc (CYTK) $523,640 $3,198,488
2022 Cytokinetics Inc (CYTK) $494,000 $2,550,548

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.